- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Diabetes Research
Volume 2016 (2016), Article ID 6785948, 11 pages
Impaired Thermogenesis and a Molecular Signature for Brown Adipose Tissue in Id2 Null Mice
Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA
Received 4 December 2015; Revised 6 March 2016; Accepted 16 March 2016
Academic Editor: Chin-Moi Chow
Copyright © 2016 Peng Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. A. Mohawk, C. B. Green, and J. S. Takahashi, “Central and peripheral circadian clocks in mammals,” Annual Review of Neuroscience, vol. 35, pp. 445–462, 2012.
- E. D. Buhr, S.-H. Yoo, and J. S. Takahashi, “Temperature as a universal resetting cue for mammalian circadian oscillators,” Science, vol. 330, no. 6002, pp. 379–385, 2010.
- Z. Gerhart-Hines, D. Feng, M. J. Emmett et al., “The nuclear receptor Rev-erbα controls circadian thermogenic plasticity,” Nature, vol. 503, no. 7476, pp. 410–413, 2013.
- S. Zvonic, A. A. Ptitsyn, S. A. Conrad et al., “Characterization of peripheral circadian clocks in adipose tissues,” Diabetes, vol. 55, no. 4, pp. 962–970, 2006.
- D. R. Van Der Veen, J. Shao, S. Chapman, W. M. Leevy, and G. E. Duffield, “A diurnal rhythm in glucose uptake in brown adipose tissue revealed by in vivo PET-FDG imaging,” Obesity, vol. 20, no. 7, pp. 1527–1529, 2012.
- T. Y. Hou, S. M. Ward, J. M. Murad, N. P. Watson, M. A. Israel, and G. E. Duffield, “ID2 (inhibitor of DNA binding 2) is a rhythmically expressed transcriptional repressor required for circadian clock output in mouse liver,” The Journal of Biological Chemistry, vol. 284, no. 46, pp. 31735–31745, 2009.
- G. E. Duffield, N. P. Watson, A. Mantani et al., “A role for Id2 in regulating photic entrainment of the mammalian circadian system,” Current Biology, vol. 19, no. 4, pp. 297–304, 2009.
- S. M. Ward, S. J. Fernando, T. Y. Hou, and G. E. Duffield, “The transcriptional repressor ID2 can interact with the canonical clock components CLOCK and BMAL1 and mediate inhibitory effects on mPer1 expression,” Journal of Biological Chemistry, vol. 285, no. 50, pp. 38987–39000, 2010.
- A. Kalsbeek, S. la Fleur, and E. Fliers, “Circadian control of glucose metabolism,” Molecular Metabolism, vol. 3, no. 4, pp. 372–383, 2014.
- D. Mathew, P. Zhou, C. M. Pywell et al., “Ablation of the ID2 gene results in altered circadian feeding behavior, and sex-specific enhancement of insulin sensitivity and elevated glucose uptake in skeletal muscle and brown adipose tissue,” PLoS One, vol. 8, no. 9, Article ID e73064, 2013.
- P. Zhou, A. D. Hummel, C. M. Pywell, X. Charlie Dong, and G. E. Duffield, “High fat diet rescues disturbances to metabolic homeostasis and survival in the Id2 null mouse in a sex-specific manner,” Biochemical and Biophysical Research Communications, vol. 451, no. 3, pp. 374–381, 2014.
- W. P. Kye, H. Waki, C. J. Villanueva et al., “Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-γ expression and adipocyte differentiation,” Molecular Endocrinology, vol. 22, no. 9, pp. 2038–2048, 2008.
- P. Zhou, R. A. Ross, C. M. Pywell, S. Liangpunsakul, and G. E. Duffield, “Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis,” Scientific Reports, vol. 4, article 3725, 2014.
- A. Pizarro, K. Hayer, N. F. Lahens, and J. B. Hogenesch, “CircaDB: a database of mammalian circadian gene expression profiles,” Nucleic Acids Research, vol. 41, no. 1, pp. D1009–D1013, 2013.
- R. Zhang, N. F. Lahens, H. I. Ballance, M. E. Hughes, and J. B. Hogenesch, “A circadian gene expression atlas in mammals: implications for biology and medicine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 45, pp. 16219–16224, 2014.
- J. R. Speakman and J. Keijer, “Not so hot: optimal housing temperatures for mice to mimic the thermal environment of humans,” Molecular Metabolism, vol. 2, no. 1, pp. 5–9, 2013.
- A. Satyanarayana, K. D. Klarmann, O. Gavrilova, and J. R. Keller, “Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis,” The FASEB Journal, vol. 26, no. 1, pp. 309–323, 2012.
- A. A. Heusner, “Body size and energy metabolism,” Annual Review of Nutrition, vol. 5, pp. 267–293, 1985.
- G. E. Duffield, “DNA microarray analyses of circadian timing: the genomic basis of biological time,” Journal of Neuroendocrinology, vol. 15, no. 10, pp. 991–1002, 2003.
- S. Mandard, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor α target genes,” Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393–416, 2004.
- A. Valmaseda, M. C. Carmona, M. J. Barberá et al., “Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes,” Molecular and Cellular Endocrinology, vol. 154, no. 1-2, pp. 101–109, 1999.
- F. Villarroya, R. Iglesias, and M. Giralt, “PPARs in the control of uncoupling proteins gene expression,” PPAR Research, vol. 2007, Article ID 74364, 12 pages, 2007.
- M. J. Barberá, A. Schlüter, N. Pedraza, R. Iglesias, F. Villarroya, and M. Giralt, “Peroxisome proliferator-activated receptor α activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell,” Journal of Biological Chemistry, vol. 276, no. 2, pp. 1486–1493, 2001.
- P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,” Cell, vol. 92, no. 6, pp. 829–839, 1998.
- E. Hondares, M. Rosell, J. Díaz-Delfín et al., “Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: Involvement of PRDM16,” Journal of Biological Chemistry, vol. 286, no. 50, pp. 43112–43122, 2011.
- M. J. Harms, J. Ishibashi, W. Wang et al., “Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice,” Cell Metabolism, vol. 19, no. 4, pp. 593–604, 2014.
- P. Seale, S. Kajimura, W. Yang et al., “Transcriptional control of brown fat determination by PRDM16,” Cell Metabolism, vol. 6, no. 1, pp. 38–54, 2007.
- C. del Carmen González, J. C. Corton, N. Acero et al., “Peroxisome proliferator-activated receptorα agonists differentially regulate inhibitor of DNA binding expression in rodents and human cells,” PPAR Research, vol. 2012, Article ID 483536, 9 pages, 2012.
- S. Kajimura, P. Seale, K. Kubota et al., “Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex,” Nature, vol. 460, no. 7259, pp. 1154–1158, 2009.
- M. Uldry, W. Yang, J. St-Pierre, J. Lin, P. Seale, and B. M. Spiegelman, “Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation,” Cell Metabolism, vol. 3, no. 5, pp. 333–341, 2006.
- K. Karaya, S. Mori, H. Kimoto et al., “Regulation of Id2 expression by CCAAT/enhancer binding protein β,” Nucleic Acids Research, vol. 33, no. 6, pp. 1924–1934, 2005.
- E. Powell, P. Kuhn, and W. Xu, “Nuclear receptor cofactors in PPARγ-mediated adipogenesis and adipocyte energy metabolism,” PPAR Research, vol. 2007, Article ID 53843, 11 pages, 2007.
- W.-J. Shen, Z. Yu, S. Patel, D. Jue, L.-F. Liu, and F. B. Kraemer, “Hormone-sensitive lipase modulates adipose metabolism through PPARγ,” Biochimica et Biophysica Acta, vol. 1811, no. 1, pp. 9–16, 2011.
- M. Schweiger, R. Schreiber, G. Haemmerle et al., “Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism,” Journal of Biological Chemistry, vol. 281, no. 52, pp. 40236–40241, 2006.
- M. Moldes, M. Boizard, X. L. Liepvre, B. Fève, I. Dugail, and J. Pairault, “Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes,” Biochemical Journal, vol. 344, no. 3, pp. 873–880, 1999.
- L. M. Grønning, R. Tingsabadh, K. Hardy et al., “Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 4, pp. E599–E606, 2006.
- H. Miki, T. Yamauchi, R. Suzuki et al., “Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation,” Molecular and Cellular Biology, vol. 21, no. 7, pp. 2521–2532, 2001.
- Y.-H. Tseng, K. M. Kriauciunas, E. Kokkotou, and C. R. Kahn, “Differential roles of insulin receptor substrates in brown adipocyte differentiation,” Molecular and Cellular Biology, vol. 24, no. 5, pp. 1918–1929, 2004.
- M. Navarro, B. Valentinis, B. Belletti, G. Romano, K. Reiss, and R. Baserga, “Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1,” Endocrinology, vol. 142, no. 12, pp. 5149–5157, 2001.
- A. Hammarstedt, S. Hedjazifar, L. Jenndahl et al., “WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 7, pp. 2563–2568, 2013.
- M. Elsen, S. Raschke, N. Tennagels et al., “BMP4 and BMP7 induce the white-to-brown transition of primary human adipose stem cells,” American Journal of Physiology-Cell Physiology, vol. 306, no. 5, pp. C431–C440, 2014.
- R. R. Bowers and M. D. Lane, “A role for bone morphogenetic protein-4 in adipocyte development,” Cell Cycle, vol. 6, no. 4, pp. 385–389, 2007.
- T. Nakahiro, H. Kurooka, K. Mori, K. Sano, and Y. Yokota, “Identification of BMP-responsive elements in the mouse Id2 gene,” Biochemical and Biophysical Research Communications, vol. 399, no. 3, pp. 416–421, 2010.
- D. Pan, M. Fujimoto, A. Lopes, and Y.-X. Wang, “Twist-1 is a PPARδ-inducible, negative-feedback regulator of PGC-1α in brown fat metabolism,” Cell, vol. 137, no. 1, pp. 73–86, 2009.
- S. Isenmann, A. Arthur, A. C. W. Zannettino et al., “TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment,” Stem Cells, vol. 27, no. 10, pp. 2457–2468, 2009.
- P. Trayhurn and S. Y. Alomar, “Oxygen deprivation and the cellular response to hypoxia in adipocytes—perspectives on white and brown adipose tissues in obesity,” Frontiers in Endocrinology, vol. 6, article 19, 2015.
- S. B. Lee, V. Frattini, M. Bansal et al., “An ID2-dependent mechanism for VHL inactivation in cancer,” Nature, vol. 529, no. 7585, pp. 172–177, 2016.
- T. Löfstedt, A. Jögi, M. Sigvardsson et al., “Induction of ID2 expression by hypoxia-inducible factor-1. A role in dedifferentiation of hypoxic neuroblastoma cells,” Journal of Biological Chemistry, vol. 279, no. 38, pp. 39223–39231, 2004.
- Y. Wang, P. M. Nishina, and J. K. Naggert, “Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng,” Journal of Endocrinology, vol. 203, no. 1, pp. 65–74, 2009.
- T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance,” Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001.
- P. D. G. Miles, Y. Barak, W. He, R. M. Evans, and J. M. Olefsky, “Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency,” Journal of Clinical Investigation, vol. 105, no. 3, pp. 287–292, 2000.